Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
NeueHealth	NEUE	4. oct 2024	5.20	-1.52
Neumora Therapeutics	NMRA	4. oct 2024	14.76	+8.97
Neuraxis	NRXS	4. oct 2024	2.92	-2.67
Neurobo Pharmaceuticals	NRBO	4. oct 2024	2.73	+3.02
Neurocrine Biosciences	NBIX	4. oct 2024	114.00	+1.89
Neurogene	NGNE	4. oct 2024	48.59	+9.41
NeuroMetrix	NURO	4. oct 2024	4.14	+1.61
Neuronetics	STIM	4. oct 2024	0.85	+7.58
NeuroOne	NMTC	4. oct 2024	0.96	+3.05
Neuropace	NPCE	4. oct 2024	6.83	-1.73
NeuroSense Therapeutics	NRSN	4. oct 2024	1.26	+3.28
Nevro	NVRO	4. oct 2024	4.97	+0.40
New America High Income Fund	HYB	4. oct 2024	8.31	+0.12
New Concept Energy	GBR	4. oct 2024	1.24	-6.33
New England Realty Associates LP Unit A	NEN	4. oct 2024	81.00	+1.25
New Fortress Energy A	NFE	4. oct 2024	10.09	+11.74
New Found Gold	NFGC	4. oct 2024	2.51	-2.71
New Germany Fund	GF	4. oct 2024	8.75	+0.03
New Gold	NGD	4. oct 2024	2.80	-1.75
New Horizon Aircraft	HOVR	4. oct 2024	0.27	+3.08
New Mountain Finance Corp	NMFC	4. oct 2024	11.85	+0.25
New Oriental Education & Technology Group ADR	EDU	4. oct 2024	80.60	+1.97
New Pacific Metals	NEWP	4. oct 2024	1.53	+1.32
New Providence Acquisition II A	NPAB	4. oct 2024	11.26	0.00
New Providence Acquisition II Unit	NPABU	4. oct 2024	11.65	0.00
New Residential Investment A Pref	RITM-A	4. oct 2024	25.90	+0.82
New Residential Investment B Pref	RITM-B	4. oct 2024	25.59	+0.18
New Residential Investment C Pref	RITM-C	4. oct 2024	24.28	-0.16
New Residential Investment D Pref	RITM-D	4. oct 2024	24.26	0.00
New York City REIT	NYC	4. oct 2024	8.88	-4.10

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.